Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
8/5/20	G1 Therapeutics Provides Second Quarter 2020 Corporate and Financial Update
8/4/20	G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August 2020
8/3/20	G1 Therapeutics and Simcere Announce Exclusive License Agreement for Trilaciclib in Greater China
7/29/20	G1 Therapeutics to Provide Second Quarter 2020 Corporate and Financial Update on August 5, 2020
7/22/20	G1 Therapeutics Announces License Agreement for Lerociclib
6/30/20	G1 Therapeutics and Boehringer Ingelheim Announce Co-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico
6/22/20	G1 Therapeutics and Genor Biopharma Announce Exclusive License Agreement for Lerociclib in Asia-Pacific Region
6/1/20	G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
5/13/20	G1 Therapeutics to Present Data Showing Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer at the ASCO20 Virtual Scientific Program
5/6/20	G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update